JNJ
227
-0.16%↓
ISRG
501.76
-0.42%↓
ABT
108.65
+2.74%↑
MDT
102.02
+1.67%↑
A
132.36
+0.02%↑
JNJ
227
-0.16%↓
ISRG
501.76
-0.42%↓
ABT
108.65
+2.74%↑
MDT
102.02
+1.67%↑
A
132.36
+0.02%↑
JNJ
227
-0.16%↓
ISRG
501.76
-0.42%↓
ABT
108.65
+2.74%↑
MDT
102.02
+1.67%↑
A
132.36
+0.02%↑
JNJ
227
-0.16%↓
ISRG
501.76
-0.42%↓
ABT
108.65
+2.74%↑
MDT
102.02
+1.67%↑
A
132.36
+0.02%↑
JNJ
227
-0.16%↓
ISRG
501.76
-0.42%↓
ABT
108.65
+2.74%↑
MDT
102.02
+1.67%↑
A
132.36
+0.02%↑
24h
Current
Min
33.45
Max
36.43
Income | 6.1M -36M |
|---|---|
Sales | 615K 12M |
EPS | -1.87 |
Profit margin | -301.289 |
Employees | 61 |
EBITDA | 6.9M -29M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +188.81% upside |
Next Earnings | 11 mar 2026 |
|---|
Market Cap | -383M 756M |
|---|---|
Previous open | 34.76 |
Previous close | 36.43 |
By Trading Central
Confidence
Strong Bearish Evidence
0.5949 / 0.7406 Support & Resistance
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
29 sty 2026, 22:31 UTC
KLA Posts Higher 2Q Profit On Product and Services Sales Growth
DJ
Read
29 sty 2026, 22:05 UTC
Stryker Logs Higher 4Q Profit On Sales Gains
DJ
Read
29 sty 2026, 21:54 UTC
Visa 1Q Sales Climb on Strong Holiday Shopping -- Update
DJ
Read
29 sty 2026, 21:36 UTC
Visa 1Q Sales Climb on Strong Holiday Shopping
DJ
Read
29 sty 2026, 23:57 UTC
Aluminum Corp. of China: to Hold 67% of Joint Venture With Rio Tinto
DJ
Read
29 sty 2026, 23:56 UTC
Aluminum Corp. of China: Deal Valued at Roughly BRL4.69 Billion
DJ
Read
29 sty 2026, 23:53 UTC
Aluminum Corp. of China Says It, Rio Tinto Propose to Buy 69% Stake in Companhia Brasileira de Aluminio S.A.
DJ
Read
29 sty 2026, 23:51 UTC
Correction to Intel Earnings Article on Jan. 22 -- WSJ
DJ
Read
29 sty 2026, 23:49 UTC
Nikkei May Decline After Wall Street Tech Selloffs -- Market Talk
DJ
Read
29 sty 2026, 23:49 UTC
Gold Rises Amid Ongoing Iran Tensions -- Market Talk
DJ
Read
29 sty 2026, 23:47 UTC
Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk
DJ
Read
29 sty 2026, 23:35 UTC
Apple Posts Blowout iPhone Sales on Surging China Demand -- 2nd Update
DJ
Read
29 sty 2026, 23:32 UTC
REA's 1H Result Could Jolt Share Price More Than Usual -- Market Talk
DJ
Read
29 sty 2026, 23:32 UTC
Global Equities Roundup: Market Talk
DJ
Read
29 sty 2026, 23:15 UTC
Visa Says High Earners Still Lead Spending Growth -- Market Talk
DJ
Read
29 sty 2026, 22:27 UTC
Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com
DJ
Read
29 sty 2026, 22:27 UTC
GE Vernova Gains After Earnings. Guidance Boost Was Enough to Lift the Stock. -- Barrons.com
DJ
Read
29 sty 2026, 22:12 UTC
Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com
DJ
Read
29 sty 2026, 21:55 UTC
Micron Stock Rises. Samsung Signals a 'Golden Era' for Memory Chips. -- Barrons.com
DJ
Read
29 sty 2026, 21:50 UTC
Financial Services Roundup: Market Talk
DJ
Read
29 sty 2026, 21:50 UTC
These Stocks Are Today's Movers: Microsoft, Meta, Tesla, Joby Aviation, SAP, Royal Caribbean, and More -- Barrons.com
DJ
Read
29 sty 2026, 21:50 UTC
Health Care Roundup: Market Talk
DJ
Read
29 sty 2026, 21:50 UTC
Auto & Transport Roundup: Market Talk
DJ
Read
29 sty 2026, 21:49 UTC
Honeywell Delivers Solid Earnings Ahead of Its Corporate Breakup -- Barrons.com
DJ
Read
29 sty 2026, 21:46 UTC
Apple Posts Blowout iPhone Sales on Surging China Demand -- Update
DJ
Read
29 sty 2026, 21:36 UTC
Lockheed Martin Stock Jumps on Guidance and Government Missile Deal -- Barrons.com
DJ
Read
29 sty 2026, 21:32 UTC
Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com
DJ
Read
29 sty 2026, 21:32 UTC
Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com
DJ
Read
29 sty 2026, 21:30 UTC
Apple Posts Blowout IPhone Sales on Surging China Demand -- WSJ
DJ
Read
29 sty 2026, 21:30 UTC
Apple 1Q Mac Rev $8.39B >AAPL
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 103.71 USD 188.81%
High 135 USD
Low 30 USD
Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
By TipRanks
Buy
8 ratings
6
Buy
1
Hold
1
Sell
Based on 8 analysts giving stock ratings to Nektar Therapeutics - Dist in the past 3 months.
By Trading Central
Short Term
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Strong Bearish Evidence
All events are bearish.
Long Term
Bearish Evidence
All events are bearish.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$